Trial run can predict who will adhere to HIV antiretrovirals
BY Advocate.com Editors
November 16 2002 1:00 AM ET
Participating in a two-week trial with mock medications before starting an actual anti-HIV drug regimen can predict how well a person will adhere to the regimen, with people who best followed dosing instructions ultimately having the best chances of achieving undetectable blood-based HIV viral loads, aidsmap.com reports. The study, conducted at two hospitals in South Carolina, showed that 75% of patients who were able to take 90% of their mock medications as directed during the two-week trial were able to achieve undetectable viral loads when given real anti-HIV drugs. Only about half of those who took less than 90% of their mock drugs on time had undetectable HIV viral loads on highly active antiretroviral therapy.
- WATCH: What Happens When a Gay Boy Scout Comes Out to His Camp Leader
- Op-ed: Are We More Successful Because We’re Gay?
- Multiple Attacks on Gay Men in NYC, Hours After Rally
- Father of Teen Facing Felony for Lesbian Relationship Says She's Been Targeted Before
- Schumer Admits Reason He Left Gays Out of Immigration 'Provides Little Comfort'
- Anonymous Boy Scouts Employee Says Antigay Policy Hurts Business
Sign Up For Email Updates
- Youth WATCH: What Happens When a Gay Scout Comes Out to Camp Leader 45 min 12 sec ago
- Commentary Op-ed: Are We More Successful Because We’re Gay? 1 hour 10 min ago
- Current Issue We Love Liberace Now Even More Than 30 Years Ago 1 hour 44 min ago
- Sports Water Polo Player Addresses WeHo City Council in Speedo May 22 2013 10:00 PM
- Comics and Graphic Novels This Gay Superhero Comic Is So Super Duper May 22 2013 9:00 PM
- The End of Bullying Could Video Games Be a Cure for Anti-LGBT Bullying? May 22 2013 8:15 PM
- Women Kaitlyn Hunt's Lawyer: Possible Plea Deal, But No Felony For Same-Sex High School Relationship May 22 2013 7:03 PM